Cargando…
Two Stage Designs for Phase III Clinical Trials
Phase III platform trials are increasingly used to evaluate a sequence of treatments for a specific disease. Traditional approaches to structure such trials tend to focus on the sequential questions rather than the performance of the entire enterprise. We consider two-stage trials where an early eva...
Autores principales: | Follmann, Dean, Proschan, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418751/ https://www.ncbi.nlm.nih.gov/pubmed/32793927 http://dx.doi.org/10.1101/2020.07.29.20164525 |
Ejemplares similares
-
Minimax and admissible adaptive two-stage designs in phase II clinical trials
por: Shan, Guogen, et al.
Publicado: (2016) -
Diagnosing fraudulent baseline data in clinical trials
por: Proschan, Michael A., et al.
Publicado: (2020) -
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
por: Qin, Fei, et al.
Publicado: (2020) -
Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials
por: Mander, A.P., et al.
Publicado: (2010) -
Correcting for selection bias in two-stage trials with multiple correlated outcomes: application to seamless phase ii/iii clinical trials
por: Robertson, David, et al.
Publicado: (2015)